News
In a new study, systemic lupus erythematosus (SLE) disease severity indicated by the presence of lupus nephritis (LN), and ...
There are several ways to maintain healthy hair and scalp when you’re living with lupus. While not all hair loss can be ...
The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment of Brad H. Rovin, MD, FACP, FASN, as Chair of its Medical-Scientific ...
The Lupus Foundation of America (LFA) and Lupus Canada are pleased to announce Mohamed Osman, MD, PhD, Associate Professor of Rheumatology at University of Alberta, as the recipient of the 2025 Lupus ...
Listen to this episode of our podcast, The Expert Series. In this month’s episode, we learn more about visible symptoms of lupus with Dr. May Choi.
The Lupus & You: Empowerment conference is an experience that celebrates, inspires, supports, and uplifts lupus warriors, care partners, family, and friends. During this empowering day, attendees will ...
A recent survey was conducted by TEAM LEWIS on behalf of the Lupus Foundation of America (LFA) to explore American’s awareness and knowledge of lupus. 1,000 individuals in the US, ages 18 or older, ...
This study is being conducted to evaluate the safety, tolerability, and ability to manufacture Descartes-08, an investigational mRNA CAR-T cell therapy, in people living with moderate to severe ...
Mesenchymal stem cells (MSCs) are unique adult stem cells with immunosuppressive properties that also may play a key role in preventing autoimmunity. In a new study, researchers identified metabolic ...
In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle intervention for people with systemic lupus erythematosus (SLE).
Today, the U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for Gazyva® (Obinutuzumab), for the potential treatment of lupus nephritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results